TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-134.0% -10.3% – – -31.4% -12.8% 1.6% 13.3% 5.5% 7.1% 2.9% -1.8%
31.7% 7.8% – – 3.6% 3.6% 2.4% 3.6% 2.4% 5.4% 3.5% 4.8%
– 0.5% – – 0.6% 0.4% 0.5% 0.8% 1.5% 2.1% 2.2% 2.4%
18.1% 7.3% – – 5.4% 2.7% 2.2% -5.4% 3.4% – – –
– -2.9% – – -11.6% -3.7% -8.2% -8.4% -7.6% -4.2% -10.1% -23.5%
93.9% 0.5% – – 1.0% 2.4% 5.2% 6.7% 7.5% 5.6% 2.1% 2.5%
-80.6% -0.4% – – -1.0% -2.4% -6.9% -6.7% -7.5% -5.6% -2.1% -2.5%
0.0% – – – – 22.2% – 0.3% 0.1% – 0.4% 2.0%
0.0% 0.0% – – 0.1% -2.6% 18.3% -0.2% -0.1% -0.1% -5.3% 0.0%
52.1% 9.0% – – 0.6% 14.6% -4.7% 0.5% -0.6% -1.2% -14.0% -0.2%
146.2% 10.9% – – 42.2% 30.2% 12.6% -0.2% -0.5% -1.3% 5.7% -3.1%
-68.5% 0.2% – – 9.8% 14.9% 7.2% 6.4% -2.5% 0.2% 6.6% -7.4%
– -10.8% – – -32.4% -15.2% -3.6% 6.6% -2.0% 1.5% 0.9% -4.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?